Citation : 2021 Latest Caselaw 1406 Guj
Judgement Date : 1 February, 2021
R/CR.MA/17496/2020 CAV JUDGMENT
IN THE HIGH COURT OF GUJARAT AT AHMEDABAD
R/CRIMINAL MISC.APPLICATION NO. 17496 of 2020
FOR APPROVAL AND SIGNATURE:
HONOURABLE MR. JUSTICE B.N. KARIA
==========================================================
1 Whether Reporters of Local Papers may be allowed to see the judgment ?
2 To be referred to the Reporter or not ?
3 Whether their Lordships wish to see the fair copy of the judgment ?
4 Whether this case involves a substantial question of law as to the interpretation of the Constitution of India or any order made thereunder ?
========================================================== HARSHAL PRAFULBHAI DESAI Versus STATE OF GUJARAT ========================================================== Appearance:
MRS R P LAKHANI(3811) for the Applicant(s) No. 1 MR DEVANG VYAS(2794), Additional Solicitor General of India for the
==========================================================
CORAM: HONOURABLE MR. JUSTICE B.N. KARIA
Date : 01/02/2021
CAV JUDGMENT
The present application is filed under Section 439 of the Code
of Criminal Procedure by the applicant for regular bail in
connection with complaint being DRI F No.
DRI/AZU/SRU/A/NDPS-01/2020 registered on 09.07.2020 with
the department of Revenue Intelligence, Surat for the offence
punishable under Sections 22, 23, 25, 25A and 29 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 ( in short "NDPS
Act").
Heard learned advocate for the applicant; learned APP for the
respondent State and learned Additional Solicitor General of India
for the respondent no.2
It was submitted by learned advocate for the applicant that
applicant is quite innocent and has not committed any of the
offence as alleged against him in the FIR and no prima facie case is
made against the present applicant. That, the applicant has been
wrongly arraigned as an accused and applicant had not committed
any offence as alleged. That applicant is one of the proprietor of
M/s. Orlando Healthcare since the year 2012 and the said firm
was engaged in trading of pharmaceutical materials. The applicant
joined M/s. Ardor Drugs Pvt. Ltd. as a director only in the year
2019. It is highly uncertain and unreliable that the applicant has
conspired and ensured to manufacture and export commercial
quantity of contraband as he had just joined Ardor Pvt. Ltd. in
2019. That, the applicant being the proprietor of M/s. Orlando
Healthcare since 2012, there is no single instance of violation of
any law much less the provisions of the NDPS Act, in the past. That
applicant has not engaged in commission of any offences as alleged
in the complaint. That a bare reading of the complaint also at no
point reveals that the applicant had any other role other than that
of being the Director of Ms. Ardor Ltd. Since the year 2019.
Further more, the applicant also doubts if the papers where the
applicant's signatures were sought were blank papers in the first
place. That the purported statement and the signature therein have
been taken by coercion, duress, involuntarily and without the free
will of the applicant herein. That applicant has been made to
testify against himself. The same is prohibited in law. That the
prosecution agency has placed a highly improbable story as the
company has already exported 44.79 Lakhs tablets and that has
gone unnoticed by the said agency and carved out a probable story
that production has been carried out by the company of 60 Lakhs
tablets, out of which, 44.79 lakhs tablets were already exported.
That the prosecution agency has first carried out a search at Hazira
Port and thereafter to shift the burden, M/s. Ardor Drugs Pvt. Ltd
and is used as a scapegoat. That retraction letters for all statements
under Section 67 of the NDPS Act have been sent since all the
statements were recorded under duress and without free will. The
statements were already drafted and the accused were forcefully
made to sign the story in order to corroborate the story of the
Investigating Authorities. Moreover, the applicant has not made
any confession/admission of the alleged offence before the DRI
officers. That applicant has denied giving the statements placed
forward by the Respondent Agency/DRI vide a retraction
correspondence. That the evidence adduced by the prosecution is
neither consistent nor convincing nor cogent nor clear. That the
recovered substance was not covered under the NDPS (Regulation
of Controlled Substances) order 2013.That even on merits looking
to the materials placed on record by the prosecution absolutely
there is no reliable or trust worthy incriminating material adduced
by the prosecution and no person can be kept behind the bar upon
such unreliable incriminating material. That the company being
Ador Drugs Pvt. Ltd received license to manufacture and export
Tramadol based drugs outside India. It is submitted that, allegedly
the company Ador Drugs Pvt Ltd. Manufactured more than 100
drugs and had received approval for the same, thus the company
was not doing anything outside the bounds of law and hence the
present applicant could not be held responsible for the alleged
offence.
Learned advocate for the applicant has referred the certificate
of renewal of license to manufacture for sale of Drugs and other
than those specified in schedule X issued in favour of M/s. Ardor
Drugs Pvt. Ltd., which is produced at Page No.36-A to 36-B i.e. list
of drugs for export to Cameroon permitting to export One Lakh
Tramadol Hydrochloride Tablet as well as letter for retraction of
statement made by the applicant and other co-accused. In support
of his arguments, learned advocate for the applicant has placed
reliance on the judgment reported in 1984 SCC (1) 284 and
judgment delivered in Criminal Appeal No. 2178 of 2011 by the
Hon'ble Supreme Court. Ultimately it was requested by learned
advocate for the applicant to allow present application by releasing
the applicant on regular bail.
From the other side, learned Additional Solicitor General of
India for the respondent No.2 has strongly objected the
submissions made by learned advocate for the applicant and
submitted that on receiving specific information by the respondent
No.2 that applicant was engaged in manufacturing of pharma
products and selling Tramadol, a psychotropic substance illicitly
through a trader M/s. Orlando Healthcare, Surat is in process of
exporting Tramadol tablets by concealing it in containers stuffed
with pharmaceutical products from the Hazira Port, a search was
carried out at the factory premises of M/s. Ardor Drugs Private Ltd.
Songadh on 06.07.2020 as well as container lying at CFS-Seabird
Marines Services Pvt. Ltd., Hazira, Surat. It is further submitted that
during the process of the panchnama at factory premises of M/s.
Ardor Drugs Private Ltd on 07.07.2020 in presence of the present
applicant and Shri Mehul Manubhai Desai and independent
panch, it was observed that there was shortage of 1376.443 kgs of
Tramadol Hydrochloride, 174.978 kgs of Ephedrine Hydrochloride
and 137.175 kgs of Pseudoephedrine Hydrochloride. It is further
submitted that present applicant and co-accused Mehul Desai
informed that they have manufactured 60 lakhs Tablets of
Tramadol Hydrochloride 225 mg from the said 1376.443 kgs. of
Tramadol Hydrochloride raw material and out of these 60 Lakhs
tablets, 15 Lakhs tablets of Tramadol Hydrochloride 225 mg were
lying at CFS-Seabird Marines Services Pvt. Ltd., Hazira, Surat for
exporting the same and remaining 44.79 Lakhs tablets have
already been exported clandestinely. It is further submitted that
container was admitted to be exported and under the panchnama
dated 06.07.2020 and 07.07.2020, total 15,20,400/- Tramadol
Hydrochloride Tables Tablet of 225 mg from the container were
recovered and placed under the seizure under the provisions of
NDPS Act. It is further submitted that statement of the applicant,
Sukhdevbhai Kantibhai Patel, Tameshwar Yograj Patle both are
chemist of M/s. Ardor Drugs Pvt. Ltd., Songadh were recorded on
07-08/07/2020 as well as Mehul Manubhai Desai under Section
67 of the NDPS Act. That the applicant himself has stated in his
statement that he is a Director of M/s. Ardor Drugs Pvt. Ltd.,
Songadh since 2019 and was engaged in illicit manufacture and
export of Tramadol Hydrochloride tablets 225 mg and with
clandestine removal of Ephedrine Hydrochloride and
Pseudoephedrine Hydrochloride. It is further submitted that
applicant himself has accepted in his statement that all such illegal
activities were done at his instructions. That applicant was fully
aware that he had illegally manufacture, sold and exported
psychotropic substances ie. Ephedrine and Pseudoephedrine with
an intention to gain money out it. That the Department of
Revenue. Ministry of Finance has issued a notification and declared
Tramadol a psychotropic substance and Ephedrine and
Pseudoephedrine substances are covered under the NDPS
( Regulation of Controlled Substances) order 2013 under Section
9(a) of the NDPS Act. It is further submitted that applicant has
controverted the provisions of Section 8(C) and 9(a) punishable
under Section 20, 23, 25, 25A and 29 of the NDPS Act. It is further
submitted that investigation is over and charge-sheet has been filed
on 29.12.2020. That detail complaint was filed wherein entire
modus operandi of the applicant and events are described that
applicant is engaged in the day to day business of his company.
That license for production of Tramadol is issued then applicant
will have to maintain certain record of sale which he did not. That
arguments advanced by learned advocate for the applicant is far
away from the facts. That present applicant has played an active
role in illegal activities in export of Tramadol tablets and also for
illicit clearance of Ephedrine and Pseudoephedrine, and therefore,
he is liable to be punished under different Sections of NDPS Act.
That he is a director of different companies and all the illegal
activities of manufacturing, selling and exporting of psychotropic
substance i.e. Tramadol 225 mg were carried out under his active
control and directions. That Tramadol HCL 225 mg tablets were
manufactured and illegally exported to M/s. Orlando Healthcare,
Surat wherein the applicant is a proprietor also a director of M/s.
Ardor Drugs Pvt. Ltd without valid permission.
While referring Section 37 of NDPS Act, learned Additional
Solicitor General of India has argued that it is necessary for the
Court to examine the question of grant of bail where Section 37 of
the NDPS Act applies. That Court should satisfy having regard to
the material available on record before passing any order. It is
further submitted that provisions of Code of Criminal Procedure
would not be applicable where different procedures having been
prescribed under the NDPS Act. Since the Act prescribes, separate
provisions for bail, general provisions of bail under the Cr.P.C. will
not be applicable in the facts and circumstances of the case.
Referring 67 of the Act, he has submitted that statement of
the applicant is admissible in evidence as it was made voluntarily
with his consent. There was no any fear, inducement or coercion. It
is further submitted that there is nothing on record to come to the
conclusion that the confessional statement of the applicant was
outcome of any threat, duress, coercion or under influence caused
to the accused by any Narcotics Control Bureau Officer. There is
sufficient material available with the prosecution and charge-sheet
is filed no leniency can be shown by this Court by accepting any
prayer to enlarge him on bail, as serious offence has been
committed by the applicant. Hence, it was requested by learned
Additional Solicitor General of India to dismiss the present
application. Learned Additional Solicitor General of India has
placed short note of written submissions on behalf of the
respondent No.2, which is taken on record and considered.
Learned APP for the respondent-State has supported the
arguments advanced by the learned Additional Solicitor General of
India and argued that applicant is prima facie, involved in the
serious offence under the NDPS Act. That sufficient material was
collected by the officer of the respondent NO.2, which clearly
shows the prima facie involvement of the present applicant in the
commission of offence. That in an offence of NDPS Act, which is
serious in nature, this Court may not accept the prayer of the
applicant and ultimately, it was requested by learned APP for the
respondent-State to dismiss present application.
Having gone through the facts and circumstances of the case
and arguments advanced by learned advocates for the respective
parties, it appears that the Director of Revenue Intelligence, Surat
has received and developed specific intelligence that M/s Ardor
Drugs Pvt. Ltd. Situated at Songadh-Ukai Road, Songadh, Tapi is
engaged in the business of manufacturing of drugs (medicines) and
also engaged in manufacturing and selling Tramadol, a
psychotropic substance illicitly and aforesaid company through
M/s. Orlando Health care Ltd, Surat is in process of exporting
Tramadol tablets by concealing it in containers stuffed with
pharma products from Hazira Port. Thereafter on 06.07.2020, a
search was carried out at factory of M/s. Ardor Drugs Pvt. Ltd. And
at CFD-Seabird Marine Services Pvt. Ltd, Hazira Port, Surat and
during the search, shortage of 1376.443 kgs of Tramadol
Hydrochloride was found and shortage of 174.978 kgs of
Ephedrine Hydrochloride IP and shortage of 137.175 kgs of
Pseudoephedrine Hydrochloride were found from the factory
premises. Upon interrogation, Mehulbhai Manubhai Desai and the
present applicant have given information that they have
manufactured 60 Lakhs tablets of Tramadol Hydrochloride of
225mg from the aforesaid short found material. Thereafter, it was
informed by the aforesaid two Directors of the company that out of
60 Lakhs tablets, 15.21 lakhs tablets are lying at CFS Seabird
Marine Services Pvt. Ltd., Hazira Port for export vide Bills
Nos.3594018 and 3614975 dated 03.07.2020 and 04.07.2020
respectively and remaining 44.79 Lakh tablets have already been
exported illicitly. That, during the search on 06.07.2020 and
07.07.2020 aforesaid 15.21 Lakh tablets were seized from two
different containers and same were recovered. Thereafter in the
statements of co-accused and one of the co-accused Mr. Sukhdev
Patel has informed the Investigating Agency that he prepares
formulations including that of Ephedrine Hydrochloride IP and
Pseudoephedrine Hydrochloride and that he was instrumental in
formulation of Tramadol Hydrochloride in formulation of
Tramadol Hydrochloride 225 Mg tablets. That, Mr. Mehulbhai
Manubhai Desai has also informed by his statement that he is a
Director of the company and is looking after the work related to
manufacturing, accounting and billing of the company and is
aware about the illicit manufacturing and export of Tramadol
Hydrochloride 225 mg. Tablets and has also accepted his offence.
That, the Investigating agency has also recorded statement of the
present applicant who is also one of the Directors of the company
and proprietor of M/s. Orlando Healthcare, Surat. During the
aforesaid statement, he informed that the said illicit or illegal
activities are done at his instruction and he is aware about illegal
manufacture, selling and export of Tramadol Tablets and illegally
sold the controlled substance with an intention to gain money out
of it. Therefore, intelligence officer has lodged a complaint against
Harshal Prafulbhai Desai (present applicant), Mehulbhai
Manubhai Desai and others for contravention of Sections 8(C) and
9(A) punishable under Sections 22, 23, 25, 25(A) and 29 of the
NDPS Act. Thereafter applicant has preferred an application under
Section 439 of the Code of Criminal Procedure, 1973 for regular
bail being Criminal Misc. Application No.3670 of 2020 before the
learned Sessions Court at Surat and the learned 3rd Additional
Sessions Judge, Surat has rejected the above mentioned application
vide order dated 30.07.2020.
Now if we peruse the certificate of renewal of license to
manufacture for sale of Drugs and other than those specified in
schedule X produced at Annexure -C collectively and Licence in
Form No.25, License No.G/25/1623 produced at Page No.36-C, it
appears that M/s. Ardor Drgus Pvt. Ltd was granted a license to
manufacture the psychotropic drugs and export the same by the
Commissioner, Food and Drugs Control Administration, Gujarat
State. It appears that time and again license of the competent
authority was renewed and valid till 4.12.2020. Admittedly search
was carried out by the prosecution at the premises of M/s. Ardor
Drugs Pvt. Ltd., Sonagadh and Hazira Port on 06.07.2020 where
the validity of the licnese was in existence. In License
No.G/25/1623, product for exporting of Tramadol Hydrochloride
BP 225 mg declares contents of Tramadol Hydrochloride BP 225
mg excipients was also approved with a quality of 1 Lakh tablets
on 12.11.2019. Now this Court would like to refer affidavit in
reply filed by the Deputy Director, Directorate of Revenue
Intelligence, Surat namely Prashant Kumar in his affidavit-in-reply
in Para 2.12, he has stated that:
"Letter FDCA/Ardor/2020/77682-84 dated 17.08.2020
issued by Commissioner, Food & Drugs Control
Administration wherein they had informed that M/s. Ardor
Drugs Pvt. Ltd. Had permission to manufacture only 101000
tablets of Tramadol Hydrochloride 225 mg with name
"Tramadol Hydrochloride Tablets BP- SUPER 225". However,
without the requisite permission, they had manufactured
Tramadol tablets/capsules in excess of the permissible limits
i.e. 101000 tablets of Tramadol Hydrochloride 225 mg and
the excess of manufactured 101000 tablets of Tramadol
Hydrochloride 225 mg were exported illegally."
From the statement on oath made by the officer of the
respondent No.2, it appears that, Commissioner of Food and Drugs
Control Administration was inquired by the prosecution and letter
thereof was issued on 17.08.2020 informing that M/s. Ardor
Drugs Pvt. Ltd had a permission to manufacture only 1 Lakh tablet
of Tramadol Hydrochloride 225 mg with name of "Tramadol
Hydrochloride BP Super 225". It appears from the letter that
Tramadol Hydrochloride were manufactured in excess of
permissible limit and exported illegally. The same thing was stated
by the office of the respondent no.2 in his affidavit in para 5 and 7:
"V. The applicant joined M/s. Ardor Drugs Pvt. Ltd. In the
month of November, 2019, however the permission bearing
No. G/25/1623 for manufacturing and export of Tramadol
225 mg. tablets to Cameroon (through M/s. Sanctuary
Pharmaceuticals) was for only 101000 Tramadol 225 mg
tablets. However the applicant in the guise of above
mentioned license, manufactured Tramadol 225 mg. tablets
more than the permissible of limit of 101000 Tramadol 225
mg tablets and got it clandestinely removed from M/s. Ardor
Drugs Pvt. Ltd. Further, out of the said tablets 15.21 lakhs
tablets were attempted to be exported from M/s. Orlando
Healthcare, Surat however the same were seized by DRI
authorities. It is pertinent to mention here that export has
been made from M/s. Orlando Healthcare (Proprietor Shri
Harshal Desai) which did not had any permission to
manufacture or export the above said Tramadol 225 mg
tablets. Hence Shri Harsahl Desai has violated the provisions
of the NDPS Act.
VII. M/s. Ardor Drugs Pvt. Ltd. got the permission for
manufacture and export of Tramadol 225 mg tablets to
Cameroon (through M/s. Sanctuary Pharmaceuticals ) for
only 101000 Tramadol 225 mg tablets. However, the
applicant in the guise of above mentioned license,
manufactured more than permissible quantity of Tramadol
225 mg tablets and got it clandestinely removed from M/s.
Ardor Drugs Pvt. Ltd. Further, 15.21 lakhs tablets were
attempted to be exported from M/s. Orlando Healthcare,
Surat, however the same were seized by DRI authorities. It is
pertinent to mention here that export has been made from
M/s. Orlando Healthcare (Proprietor Shri Harshal Desai)
which did not had any permission to manufacture or export
the above said Tramadol 225 mg tablets. Department of
Revenue, Ministry of Finance vide Notification S.O 1761(E)
dated 26.4.2018 has declared Tramadol a psychotropic
substance at Sr. No. 110Y of the Schedule wherein list of
psychotropic substances are mentioned. Further, Department
of Revenue, Ministry of Financier vide Notification S.O
1762(E) dated 26.4.2018 has declared 250gm as the
commercial quantity for Tramadol."
What is necessary for the Court to examine the question of
grant of bail where section 37 applies is that the court should be
satisfied having regard to the material available on record as there
are sufficient grounds with the applicant that he may not be
convicted. If probabilities are that the applicant can not be
convicted then the court can grant bail subject to further
conditions being satisfied that the applicant is not likely to commit
any offence while on bail. The language of Section 37 is clear that
the Section is not a complete bar to the grant of bail to an accused
of offence under the NDPS Act. This section stipulates mandatory
conditions to be satisfied that the person-accused under the NDPS
Act is entitled to be released on bail. The first condition is that the
prosecution must be given an opportunity to oppose the application
and the second, is that the court must be satisfied that there are
reasonable grounds for believing that he is not guilty of such
offence and finally that the accused is not likely to be committed
any offence while on bail.
Here it is the case of the applicant that the statement of the
applicant was recorded without free will and he was forced to sign
on already prepared statement. The statement was recorded under
duress and without consent. That, it is reflected from the letter for
retraction of statement is also produced by him at Annexure-D to
this petition and such a confessional statement can be disregarded
if it is shown that the same was caused by the inducement, threat
or promise etc by the person in authority as enumerated under
Section 24 of the Evidence Act. This action would be a question of
fact, which can be decided only after conclusion of the trial.
This Court would like to refer the judgment of the Hon'ble
Apex Court passed in Criminal Appeal No. 949 of 2018
wherein statement of the accused recorded under Section 67 of the
Act was discussed. Hon'ble Supreme Court, in para 5, 6, 7 and 8 in
such judgment, has observed as under:
5. As regards the appellant, it was observed by the High Court that he was specifically named by co-accused Raj Kumar @ Raju and Surinder Pal Singh in their statements. Apart from such statements nothing was produced on record to indicate the involvement of the appellant. The High Court however found that the case against the appellant was made out. It was
observed:
"Offence of abetment under Section 29 of NDPS Act stood established against accused Surinder Kumar Khanna, showing that he was involved in drug trafficking. He was specifically named by accused Raj Kumar @ Raju and Surinder Pal Singh in their statements. Such statements of accused Raj Kumar @ Raju and Surinder Pal Singh recorded under Section 67 of the NDPS Act are admissible in evidence and are not hit by Section 25 of the Evidence Act because the officers of DRI, who had apprehended Raj Kumar @ Raju and Surinder Pal Singh, traveling in an Indica car and effecting recovery from them do not come within the definition of police officers.".
The High Court thus affirmed the order of conviction as recorded against the appellant but reduced the sentence to rigorous imprisonment for a period of 10 years and to pay fine of Rs.1 lakh, in default whereof to undergo further rigorous imprisonment for 1½ years. Similar orders of sentence were passed in respect of other co-accused namely Raj Kumar @ Raju and Surinder Pal Singh.
6. In this appeal challenging the correctness of the conviction and sentence rendered as against the appellant, it was submitted by Mr. Jayant Bhushan, learned Senior Advocate that apart from the so called statements of co-accused Raj Kumar @ Raju and Surinder Pal Singh there was nothing against the appellant and that he was neither arrested at the site nor was the contraband material in any way associated with him. Mr. Maninder Singh, learned Additional Solicitor General appearing for the respondent however supported the judgment of conviction and sentence rendered against the appellant. He placed on record call data reports showing that around the time when the co-accused was arrested, the appellant was in touch with a person named Chaudhary from Dubai. The learned Additional Solicitor General however fairly accepted that apart from the statements of the co- accused there was nothing to link the appellant with said convicted accused. The call data reports also did not indicate that around the time when co- accused were apprehended, the appellant was in touch with either of them.
7. For the present purposes, we will proceed on the footing that the statements of co-accused were recorded under and in terms of Section 67 of the NDPS Act. As regards such statements, a bench of two Judges of this
Court after referring to and relying upon the earlier Judgments, observed in Kanhaiyalal v. Union of India1, as under:
"45. Considering the provisions of Section 67 of the NDPS Act and the views expressed by this Court in Raj Kumar Karwal case2 with which we agree, that an officer vested with the powers of an officer in charge of a police station under Section 53 of the above Act is not a "police officer" within the meaning of Section 25 of the Evidence Act, it is clear that a statement made under Section 67 of the NDPS Act is not the same as a statement made under Section 161 of the (2008) 4 SCC 668 (1990) 2 SCC 409 Code, unless made under threat or coercion. It is this vital difference, which allows a statement made under Section 67 of the NDPS Act to be used as a confession against the person making it and excludes it from the operation of Sections 24 to 27 of the Evidence Act."
8. Later, another bench of two Judges of this Court in Tofan Singh v. State of Tamil Nadu3 was of the view that the matter required reconsideration and therefore, directed that the matter be placed before a larger bench. It was observed in Tofan Singh (supra) as under:
"40. In our view the aforesaid discussion necessitates a re-look into the ratio of Kanhaiyalal case. It is more so when this Court has already doubted the dicta in Kanhaiyalal in Nirmal Singh Pehlwan4 wherein after noticing both Kanhaiyalal as well as Noor Aga5, this Court observed thus: (Nirmal Singh Pehlwan case, SCC p. 302, para 15) "15. We also see that the Division Bench in Kanhaiyalal case had not examined the principles and the concepts underlying Section 25 of the Evidence Act, 1872 vis-à-vis Section 108 of the Customs Act and the powers of a Customs Officer who could investigate and bring for trial an accused in a narcotic matter. The said case relied exclusively on the judgment in Raj Kumar case. The latest judgment in point of time is Noor Aga case which has dealt very elaborately with this matter. We thus feel it would be proper for us to follow the ratio of the judgment in Noor Aga case particularly as the provisions of Section 50 of the Act which are mandatory have also not been complied with." (2013) 16 SCC 31 (2011) 12 SCC 298 (2008) 16 SCC 417
41. For the aforesaid reasons, we are of the view that the matter needs to be referred to a larger Bench for reconsideration of the issue as to whether the officer investigating the matter under the NDPS Act would qualify as police officer or not.
42. In this context, the other related issue viz. whether the statement recorded by the investigating officer under Section 67 of the Act can be treated as confessional statement or not, even if the officer is not treated as police officer also needs to be referred to the larger Bench, inasmuch as it is intermixed with a facet of the 1st issue as to whether such a statement is to be treated as statement under Section 161 of the Code or it partakes the character of statement under Section 164 of the Code."
As the issue of considering the statement under Section 67 of
the NDPS Act can be constrained as a confessional statement and
same was referred to larger bench, thereafter, on the premise that
such statement under Section 67 of the NDPS Act was recorded,
Hon'ble Apex Court has proceeded further observing that it may
amount to confession, but certain additional features must be
established before such a confessional statement could be relied
upon against a co-accused.
Referring another judgment of the Hon'ble Apex court, it was
held that it cannot by itself be taken as a substantive piece of
evidence against another co-accused and can at best be used or
utilized in order to lend assurance to the Court, therefore,
appellant was entitled to be acquired of the charges levelled against
him.
In another case of "Sujit Tiwari versus State of
Gujarat and Another" reported in 2020(1) Crimes 141(SC),
while deciding bail application under the NDPS Act, Hon'ble
Supreme Court has observed the provisions of Sections 36(A), 37 of
the NDPS Act. In this case, huge quantity of Narcotic substances
from the Ship was found and seized. The prosecution mainly relied
in view the bar of Section 37 of the NDPS Act and statement made
by the accused under Section 67 of the NDPS Act. Hon'ble Supreme
Court has observed that without going into the question whether
the statement is admissible or not, matter has been referred to a
larger bench, for the purpose of this case. Taking the statement into
consideration even though the accused has resiled from the same,
Hon'ble Apex Court was pleased to accept the prayer by granting
bail with stringent conditions.
Considering the peculiar facts of the present case, as the issue
of admissibility of the statement recorded under Section 67 of the
Act is referred to the larger bench. In the present case also,
statement of the applicant is recorded. It is stated that his statement
was under duress and without his consent. Annexure-D shows that
he has reiterated his statement saying that it was not given
voluntarily by him and he is forced to give the same before the
Officer of the Department of Revenue Intelligence under duress
and without free will. Further as admitted by Mr. Prashant Kumar
in his affidavit in reply Page 43 of the petition that M/s. Ardor
Drugs Private Limited got one time permission for manufacture
and export of Tramadol Hydrochloride 225 Mg tablets to
Cameroon (through M/s. Sanctuary Pharmaceuticals) for only
101000 Tramadol 225 mg tablets. However, applicant in the guise
of above mentioned licence, manufactured more than permissible
quantity of Tramadol 225 mg tablets and got it clandestinely
removed from M/s. Ardor Drugs Private Limited. Therefore, under
the facts and circumstances of this case, this Court feels that this is
a fit case whether the applicant is entitled to bail because there is a
possibility that he may not be convicted under the provisions as
charged by the respondent no.2 after recording evidence of eye
witnesses. This Court is satisfied having regard to the material
available on record and there are sufficient grounds that if the
applicant may not be convicted.
Further, the applicant has no antecedent and trail would take
long time. He is not likely to run away from the justice if he is
released on bail, as he is a Director of different companies situated
at Songadh District Tapi.
If the probabilities are there, the applicant may not be
convicted, court can grant bail subject to further conditions being
satisfied that the applicant is not likely to commit any offence while
on bail.
After filing of the the chargesheet during the pendency of this
application, no further evidence is placed on record involving the
present applicant in the offence, and therefore, this court feels that
some stringent conditions will have to be imposed upon the
applicant by accepting the prayer.
Hence, the present application is allowed and the applicant
namely Harshal Prafulbhai Desai is ordered to be released on
regular bail in connection with complaint being DRI F No.
DRI/AZU/SRU/A/NDPS-01/2020 registered on 09.07.2020 with
the department of Revenue Intelligence, Surat upon furnishing bail
bond of sum of Rs. 5,00,000/- (Rupees Five lacs only) with two
sureties of the like amount to the satisfaction of the Special Judge,
NDPS Court at Surat and subject to the conditions that the
applicant shall;
[a] not take undue advantage of liberty or misuse liberty;
[b] not act in a manner injurious to the interest of the prosecution;
[c] surrender passport, if any, to the Special Court of NDPS at Surat within a week;
[d] not leave the State of Gujarat without prior permission of the Sessions Judge concerned and not go to any other place;
[e] furnish latest and permanent address of residence to the Investigating Officer and also to the Court at the time of execution of the bond and shall not change the residence without prior permission of the learned Sessions Court concerned;
[f] provide his cell phone number to the respondent no2. Authority and shall not change his cell phone without permission of the trial Court.
[g] not in any manner try to delay the trial once it commences.
If the applicant fails in comply with these conditions,
respondent no.2 shall be entitled to straightway apply to the Special
Judge for cancellation of his bail.
The Authorities will release the applicant only if he is not
required in connection with any other offence for the time being. If
breach of any of the above conditions is committed, the Sessions
Judge concerned will be free to issue warrant or take appropriate
action in the matter. Bail bond to be executed before the learned
Lower Court having jurisdiction to try the case. It will be open for
the concerned Court to delete, modify and/or relax any of the
above conditions, in accordance with law. At the trial, learned Trial
Court shall not be influenced by the observations of preliminary
nature, qua the evidence at this stage, made by this Court while
enlarging the applicant on bail.
Rule is made absolute to the aforesaid extent.
This order be communicated to the applicant through Jail
Authorities by the registry as well as learned Sessions Court
concerned.
(B.N. KARIA, J) K. S. DARJI
Publish Your Article
Campus Ambassador
Media Partner
Campus Buzz
LatestLaws.com presents: Lexidem Offline Internship Program, 2026
LatestLaws.com presents 'Lexidem Online Internship, 2026', Apply Now!